Ziegler Capital Management LLC trimmed its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 1.6% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 8,063 shares of the biopharmaceutical company’s stock after selling 132 shares during the […]
Achmea Investment Management B.V. trimmed its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 29.9% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 14,518 shares of the biopharmaceutical company’s stock after selling 6,204 shares during the quarter. Achmea Investment Management B.V.’s […]
Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Cut to $900 00 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target decreased by Wells Fargo & Company from $915.00 to $875.00 in a report issued on Wednesday, The Fly reports. Other equities analysts have also issued research reports about the company. Raymond James raised Regeneron Pharmaceuticals from an underperform rating to a market perform rating in […]
Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its target price cut by Robert W. Baird from $800.00 to $760.00 in a research note issued on Wednesday, The Fly reports. Robert W. Baird’s price target would suggest a potential upside of 7.28% from the company’s current price. A number of other analysts have also recently weighed […]